The Society of Hematologic Oncology (SOHO) Annual Meeting will be held virtually from 08-11 September 2021.
View all videos

SOHO 2021

08–11 September 2021

Marco Herling of @UniLeipzig discusses the safety and efficacy of tagraxofusp for the treatment of BPDCN:

🎥: http://ow.ly/hq9y50JGpAF

@EHA_Hematology #EHA2022 #RareDiseases #BPDCN

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

Want to learn more about myeloma treatment in the UK?

Join experts Graham Jackson (@profghjackson) & Martin Kaiser in this exclusive session as they discuss:

- Muk Nine b: OPTIMUM
- Myeloma XI
- Genomics in myeloma

& more!

👉http://ow.ly/qqgH50JEOpX👈

#MMsm #HemOnc

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

On June 24, the @US_FDA approved lisocabtagene maraleucel (liso-cel) for second-line treatment of adult patients with LBCL. The efficacy of liso-cel has been evaluated in the TRANSFORM study.

Find out more here:

👉http://ow.ly/QqNu50JJj3z👈

#LymSM #HemOnc #CARTcell #ImmunoOnc

Load More...

SOHO 2021

08–11 September 2021
The Society of Hematologic Oncology (SOHO) Annual Meeting will be held virtually from 08-11 September 2021.
View all videos

Marco Herling of @UniLeipzig discusses the safety and efficacy of tagraxofusp for the treatment of BPDCN:

🎥: http://ow.ly/hq9y50JGpAF

@EHA_Hematology #EHA2022 #RareDiseases #BPDCN

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

Want to learn more about myeloma treatment in the UK?

Join experts Graham Jackson (@profghjackson) & Martin Kaiser in this exclusive session as they discuss:

- Muk Nine b: OPTIMUM
- Myeloma XI
- Genomics in myeloma

& more!

👉http://ow.ly/qqgH50JEOpX👈

#MMsm #HemOnc

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

On June 24, the @US_FDA approved lisocabtagene maraleucel (liso-cel) for second-line treatment of adult patients with LBCL. The efficacy of liso-cel has been evaluated in the TRANSFORM study.

Find out more here:

👉http://ow.ly/QqNu50JJj3z👈

#LymSM #HemOnc #CARTcell #ImmunoOnc

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter